9 Meters Biopharma, Inc.
CIK 0001551986
Revenue (TTM)
—
Q1 May 2023
Net Income (TTM)
−$45.7M
−19.0% YoY
Q1 May 2023
EPS Diluted (TTM)
−$2.66
−11.6% YoY
Q1 May 2023
Gross Margin
—
Q1 May 2023
Operating Margin
—
Q1 May 2023
Net Margin
—
Q1 May 2023
Free Cash Flow (TTM)
−$28.36M
Q1 May 2023
Cash
$6.94M
Q1 May 2023
Total Debt
$18.39M
Q1 May 2023
Shares Outstanding
14.46M sh
Q1 May 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.